Imugene Limited (IMU.AX)
AUD 0.02
(-4.0%)
AUD 0.02
(-4.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 135.09 Million AUD | 175.19% |
| 2023 | 49.08 Million AUD | 1.71% |
| 2022 | 48.26 Million AUD | 103.62% |
| 2021 | 23.7 Million AUD | 60.2% |
| 2020 | 14.79 Million AUD | 20.05% |
| 2019 | 12.32 Million AUD | 113.42% |
| 2018 | 5.77 Million AUD | 56.8% |
| 2017 | 3.68 Million AUD | -13.7% |
| 2016 | 4.26 Million AUD | 47.95% |
| 2015 | 2.88 Million AUD | 115.94% |
| 2014 | 1.33 Million AUD | -23.2% |
| 2013 | 1.73 Million AUD | 23.95% |
| 2012 | 1.4 Million AUD | -25.67% |
| 2011 | 1.88 Million AUD | -11.07% |
| 2010 | 2.12 Million AUD | -23.01% |
| 2009 | 2.75 Million AUD | 7.7% |
| 2008 | 2.56 Million AUD | -15.84% |
| 2007 | 3.04 Million AUD | -3.49% |
| 2006 | 3.15 Million AUD | 25.44% |
| 2005 | 2.51 Million AUD | 2.94% |
| 2004 | 2.44 Million AUD | 0.53% |
| 2003 | 2.42 Million AUD | 640.41% |
| 2002 | 328 Thousand AUD | -87.28% |
| 2001 | 2.57 Million AUD | 158.58% |
| 2000 | -4.4 Million AUD | 10.24% |
| 1999 | -4.9 Million AUD | -8.52% |
| 1998 | -4.51 Million AUD | -424.34% |
| 1997 | 1.39 Million AUD | 59.93% |
| 1996 | 871 Thousand AUD | -6.84% |
| 1995 | 935 Thousand AUD | 22.06% |
| 1994 | 766 Thousand AUD | 192.37% |
| 1993 | 262 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 67.55 Million AUD | 0.0% |
| 2024 FY | 135.09 Million AUD | 175.19% |
| 2024 Q2 | 79.23 Million AUD | 0.0% |
| 2023 FY | 49.08 Million AUD | 1.71% |
| 2023 Q4 | 29.38 Million AUD | 0.0% |
| 2023 Q2 | 21.9 Million AUD | 0.0% |
| 2022 Q4 | 30.15 Million AUD | 0.0% |
| 2022 FY | 48.26 Million AUD | 103.62% |
| 2022 Q2 | 20.52 Million AUD | 0.0% |
| 2021 FY | 23.7 Million AUD | 60.2% |
| 2021 Q2 | 10.14 Million AUD | 0.0% |
| 2021 Q4 | 15.52 Million AUD | 0.0% |
| 2020 Q2 | 7.25 Million AUD | 0.0% |
| 2020 FY | 14.79 Million AUD | 20.05% |
| 2020 Q4 | 7.62 Million AUD | 0.0% |
| 2019 Q2 | 5.26 Million AUD | 0.0% |
| 2019 FY | 12.32 Million AUD | 113.42% |
| 2019 Q4 | 6.99 Million AUD | 0.0% |
| 2018 Q2 | 2.35 Million AUD | 0.0% |
| 2018 FY | 5.77 Million AUD | 56.8% |
| 2018 Q4 | 3.51 Million AUD | 0.0% |
| 2017 Q2 | 2.27 Million AUD | 0.0% |
| 2017 FY | 3.68 Million AUD | -13.7% |
| 2017 Q4 | 1.43 Million AUD | 0.0% |
| 2016 FY | 4.26 Million AUD | 47.95% |
| 2016 Q4 | 2.6 Million AUD | 0.0% |
| 2016 Q2 | 1.68 Million AUD | 0.0% |
| 2015 Q2 | 1.53 Million AUD | 0.0% |
| 2015 FY | 2.88 Million AUD | 115.94% |
| 2015 Q4 | 1.54 Million AUD | 0.0% |
| 2014 Q2 | 1.51 Million AUD | 0.0% |
| 2014 FY | 1.33 Million AUD | -23.2% |
| 2014 Q4 | 1.13 Million AUD | 0.0% |
| 2013 Q3 | 434.68 Thousand AUD | -65.25% |
| 2013 Q4 | 515.91 Thousand AUD | 18.69% |
| 2013 Q2 | 1.25 Million AUD | 1238.95% |
| 2013 Q1 | 93.42 Thousand AUD | 0.0% |
| 2013 FY | 1.73 Million AUD | 23.95% |
| 2012 FY | 1.4 Million AUD | -25.67% |
| 2012 Q4 | 93.42 Thousand AUD | 0.0% |
| 2012 Q3 | 93.42 Thousand AUD | 0.0% |
| 2012 Q2 | 93.42 Thousand AUD | 213.3% |
| 2012 Q1 | 29.81 Thousand AUD | 0.0% |
| 2011 FY | 1.88 Million AUD | -11.07% |
| 2011 Q4 | 29.81 Thousand AUD | 0.0% |
| 2011 Q3 | 29.81 Thousand AUD | 0.0% |
| 2011 Q2 | 29.81 Thousand AUD | -57.53% |
| 2011 Q1 | 70.2 Thousand AUD | 0.0% |
| 2010 Q1 | 65.04 Thousand AUD | 0.0% |
| 2010 Q2 | 70.2 Thousand AUD | 7.93% |
| 2010 Q4 | 70.2 Thousand AUD | 0.0% |
| 2010 Q3 | 70.2 Thousand AUD | 0.0% |
| 2010 FY | 2.12 Million AUD | -23.01% |
| 2009 Q2 | 65.04 Thousand AUD | 580.93% |
| 2009 Q4 | 65.04 Thousand AUD | 0.0% |
| 2009 Q3 | 65.04 Thousand AUD | 0.0% |
| 2009 FY | 2.75 Million AUD | 7.7% |
| 2009 Q1 | 9552.50 AUD | 0.0% |
| 2008 Q1 | 120.32 Thousand AUD | 0.0% |
| 2008 FY | 2.56 Million AUD | -15.84% |
| 2008 Q4 | 9552.50 AUD | 0.0% |
| 2008 Q3 | 9552.50 AUD | 0.0% |
| 2008 Q2 | 9552.50 AUD | -92.06% |
| 2007 Q2 | 120.32 Thousand AUD | -58.0% |
| 2007 Q4 | 120.32 Thousand AUD | 0.0% |
| 2007 FY | 3.04 Million AUD | -3.49% |
| 2007 Q1 | 286.49 Thousand AUD | 0.0% |
| 2007 Q3 | 120.32 Thousand AUD | 0.0% |
| 2006 Q3 | 286.49 Thousand AUD | 0.0% |
| 2006 FY | 3.15 Million AUD | 25.44% |
| 2006 Q4 | 286.49 Thousand AUD | 0.0% |
| 2006 Q2 | 286.49 Thousand AUD | 199.46% |
| 2006 Q1 | 95.67 Thousand AUD | 0.0% |
| 2005 FY | 2.51 Million AUD | 2.94% |
| 2005 Q4 | 95.67 Thousand AUD | 0.0% |
| 2005 Q1 | 105.7 Thousand AUD | 0.0% |
| 2005 Q3 | 95.67 Thousand AUD | 0.0% |
| 2005 Q2 | 95.67 Thousand AUD | -9.49% |
| 2004 FY | 2.44 Million AUD | 0.53% |
| 2004 Q3 | 105.7 Thousand AUD | 0.0% |
| 2004 Q2 | 105.7 Thousand AUD | -47.42% |
| 2004 Q1 | 201.04 Thousand AUD | 0.0% |
| 2004 Q4 | 105.7 Thousand AUD | 0.0% |
| 2003 Q4 | 201.04 Thousand AUD | 0.0% |
| 2003 FY | 2.42 Million AUD | 640.41% |
| 2003 Q3 | 201.04 Thousand AUD | 0.0% |
| 2003 Q1 | 82.26 Thousand AUD | 0.0% |
| 2003 Q2 | 201.04 Thousand AUD | 144.38% |
| 2002 Q1 | 140.58 Thousand AUD | 0.0% |
| 2002 Q3 | 82.26 Thousand AUD | 0.0% |
| 2002 FY | 328 Thousand AUD | -87.28% |
| 2002 Q2 | 82.26 Thousand AUD | -41.48% |
| 2002 Q4 | 82.26 Thousand AUD | 0.0% |
| 2001 Q1 | -2.2 Million AUD | 0.0% |
| 2001 Q3 | 140.58 Thousand AUD | 0.0% |
| 2001 Q4 | 140.58 Thousand AUD | 0.0% |
| 2001 FY | 2.57 Million AUD | 158.58% |
| 2001 Q2 | 140.58 Thousand AUD | 106.38% |
| 2000 Q2 | -2.2 Million AUD | 10.29% |
| 2000 Q4 | -2.2 Million AUD | 0.0% |
| 2000 Q3 | -2.2 Million AUD | 0.0% |
| 2000 FY | -4.4 Million AUD | 10.24% |
| 2000 Q1 | -2.45 Million AUD | 0.0% |
| 1999 Q4 | -2.45 Million AUD | 0.0% |
| 1999 Q2 | -2.45 Million AUD | -8.48% |
| 1999 Q3 | -2.45 Million AUD | 0.0% |
| 1999 Q1 | -2.26 Million AUD | 0.0% |
| 1999 FY | -4.9 Million AUD | -8.52% |
| 1998 Q2 | -2.26 Million AUD | 0.0% |
| 1998 Q3 | -2.26 Million AUD | 0.0% |
| 1998 Q1 | - AUD | 0.0% |
| 1998 Q4 | -2.26 Million AUD | 0.0% |
| 1998 FY | -4.51 Million AUD | -424.34% |
| 1997 Q3 | - AUD | 0.0% |
| 1997 FY | 1.39 Million AUD | 59.93% |
| 1997 Q4 | - AUD | 0.0% |
| 1997 Q2 | - AUD | -100.0% |
| 1997 Q1 | 217.75 Thousand AUD | 0.0% |
| 1996 Q4 | 217.75 Thousand AUD | 0.0% |
| 1996 Q3 | 217.75 Thousand AUD | 0.0% |
| 1996 FY | 871 Thousand AUD | -6.84% |
| 1996 Q2 | 217.75 Thousand AUD | -6.84% |
| 1996 Q1 | 233.75 Thousand AUD | 0.0% |
| 1995 FY | 935 Thousand AUD | 22.06% |
| 1995 Q1 | -191.5 Thousand AUD | 0.0% |
| 1995 Q2 | 233.75 Thousand AUD | 222.06% |
| 1995 Q3 | 233.75 Thousand AUD | 0.0% |
| 1995 Q4 | 233.75 Thousand AUD | 0.0% |
| 1994 Q4 | -191.5 Thousand AUD | 0.0% |
| 1994 Q2 | -191.5 Thousand AUD | -192.37% |
| 1994 Q3 | -191.5 Thousand AUD | 0.0% |
| 1994 FY | 766 Thousand AUD | 192.37% |
| 1994 Q1 | -65.5 Thousand AUD | 0.0% |
| 1993 Q4 | -65.5 Thousand AUD | 0.0% |
| 1993 FY | 262 Thousand AUD | 0.0% |
| 1993 Q2 | -65.5 Thousand AUD | 0.0% |
| 1993 Q3 | -65.5 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | -1895.579% |
| Acrux Limited | 8.55 Million AUD | -1480.01% |
| Actinogen Medical Limited | 22.77 Million AUD | -493.271% |
| AnteoTech Limited | 12.18 Million AUD | -1008.483% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -1533.675% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -1152.548% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -18921.067% |
| Alterity Therapeutics Limited | 23.4 Million AUD | -477.146% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -1501.414% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -2872.038% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -4792.798% |
| Biome Australia Limited | 7.91 Million AUD | -1607.585% |
| Biotron Limited | 5.11 Million AUD | -2543.307% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -22347.052% |
| BTC Health Limited | -1.03 Million AUD | 13102.92% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | -583.404% |
| CSL Limited | 7.56 Billion AUD | 98.213% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | -139.917% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | -331.641% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -1114.456% |
| Dimerix Limited | 25.64 Million AUD | -426.808% |
| EZZ Life Science Holdings Limited | 39.57 Million AUD | -241.359% |
| Hexima Limited | 1 Million AUD | -13291.906% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -3174.647% |
| Immuron Limited | 9.13 Million AUD | -1378.355% |
| Immutep Limited | 42.87 Million AUD | -215.079% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -3937.525% |
| Memphasys Limited | 3.67 Million AUD | -3572.562% |
| Nanollose Limited | 12.5 Thousand AUD | -1080540.333% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | -313.16% |
| Noxopharm Limited | 7 Million AUD | -1829.817% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -6774.079% |
| Nyrada Inc. | 4.55 Million AUD | -2865.661% |
| Orthocell Limited | 15.36 Million AUD | -778.952% |
| PharmAust Limited | 6.65 Million AUD | -1929.309% |
| Patrys Limited | 4.93 Million AUD | -2638.339% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | -107.503% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -15042.286% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -1139.504% |
| PYC Therapeutics Limited | 60.91 Million AUD | -121.764% |
| Race Oncology Limited | 14.77 Million AUD | -814.601% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -45046.46% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | -522.984% |
| Starpharma Holdings Limited | 22.81 Million AUD | -492.088% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 49.83% |
| Tissue Repair Ltd | 6.66 Million AUD | -1926.319% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -2171.002% |